长链非编码RNA与肿瘤

doi:10.3760/cma.j.issn.1673422X.2014.01.003

摘要/Abstract

摘要： 长链非编码RNA（lncRNA）是重要的基因表达调控因子，它广泛参与多种生理及病理过程。近年来研究证实lncRNA与肿瘤密切相关，并显露出作为肿瘤诊断和治疗新靶点的潜能。

Abstract: Long non-coding RNA （lncRNA） is widely associated with varies physiological and pathological processes as a critical regulator of gene expression. Recent researches demonstrate that lncRNA is closely related with tumor, and a new potential of lncRNA is revealed as a new target for tumor diagnosis and therapy.

Key words: Neoplasms, Gene expression regulation, Long non-coding RNA

徐玥, 仲飞, 孙国平. 长链非编码RNA与肿瘤[J]. 国际肿瘤学杂志, 2014, 41(1): 7-11.

XU Yue, ZHONG Fei, SUN Guo-Ping. Long non-coding RNA and tumor[J]. Journal of International Oncology, 2014, 41(1): 7-11.

参考文献

［1］ Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression［J］. Genome Res, 2012, 22(9):17751789. ［2］ Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs［J］. Mol Cell, 2011, 43(6):904914. ［3］ Gutschner T, Hmmerle M, Eissmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells［J］. Cancer Res, 2013, 73(3):11801189. ［4］ Schmidt LH, Spieker T, Koschmieder S, et al. The long noncoding MALAT1 RNA indicates a poor prognosis in nonsmall cell lung cancer and induces migration and tumor growth［J］. J Thorac Oncol, 2011, 6(12):19841992. ［5］ Tano K, Mizuno R, Okada T, et al. MALAT1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motilityrelated genes［J］. FEBS Lett, 2010, 584(22):45754580. ［6］ Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor BMYB［J］. PLoS Genet, 2013, 9(3):e1003368. ［7］ Tsang WP, Ng EK, Ng SS, et al. Oncofetal H19derived miR675 regulates tumor suppressor RB in human colorectal cancer［J］. Carcinogenesis, 2010, 31(3):350358. ［8］ Zhang L, Yang F, Yuan JH, et al. Epigenetic activation of the miR200 family contributes to H19mediated metastasis suppression in hepatocellular carcinoma［J］. Carcinogenesis, 2013, 34(3):577586. ［9］ Huang JF, Guo YJ, Zhao CX, et al. Hepatitis B virus X protein (HBx)related long noncoding RNA (lncRNA) downregulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin［J］. Hepatology, 2013, 57(5):18821892. ［10］ Pan YF, Qin T, Feng L, et al. Expression profile of altered long noncoding RNAs in patients with HBVassociated hepatocellular carcinoma［J］. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(1):96101. ［11］ Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans［J］. Hepatology, 2011, 54(5):16791689. ［12］ Lu L, Zhu G, Zhang C, et al. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer［J］. Breast Cancer Res Treat, 2012, 136(3):875883. ［13］ Nakagawa T, Endo H, Yokoyama M, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short diseasefree survival in human nonsmall cell lung cancer［J］. Biochem Biophys Res Commun, 2013, 436(2):319324. ［14］ Lv XB, Lian GY, Wang HR, et al. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival［J］. PLoS One, 2013, 8(5):e63516. ［15］ Wu W, Bhagat TD, Yang X, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1AS1, in Barrett′s esophagus and esophageal adenocarcinoma［J］. Gastroenterology, 2013, 144(5):956966. ［16］ Hajjari M, Behmanesh M, Sadeghizadeh M, et al. Upregulation of HOTAIR long noncoding RNA in human gastric adenocarcinoma tissues［J］. Med Oncol, 2013, 30(3):670. ［17］ Xu ZY, Yu QM, Du YA, et al. Knockdown of long noncoding RNA HOTAIR suppresses tumor invasion and reverses epithelialmesenchymal transition in gastric cancer［J］. Int J Biol Sci, 2013, 9(6):587597. ［18］ Arita T, Ichikawa D, Konishi H, et al. Circulating long noncoding RNAs in plasma of patients with gastric cancer［J］. Anticancer Res, 2013, 33(8):31853193. ［19］ Kam Y, Rubinstein A, Naik S, et al. Detection of a long noncoding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FITPNA molecular beacons［J］. Cancer Lett, 2013, In press. ［20］ Ling H, Spizzo R, Atlasi Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer［J］. Genome Res, 2013, 23(9):14461461. ［21］ Bhan A, Hussain I, Ansari KI, et al. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol［J］. J Mol Biol, 2013, 425(19):37073722. ［22］ Chisholm KM, Wan Y, Li R, et al. Detection of long noncoding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma［J］. PLoS One, 2012, 7(10):e47998. ［23］ Augoff K, McCue B, Plow EF, et al. MiR31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triplenegative breast cancer［J］. Mol Cancer, 2012, 11:5. ［24］ Qin R, Chen Z, Ding Y, et al. Long noncoding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis［J］. Neoplasma, 2013, 60(5):486492. ［25］ Pickard MR, MourtadaMaarabouni M, Williams GT. Long noncoding RNA GAS5 regulates apoptosis in prostate cancer cell lines［J］. Biochim Biophys Acta, 2013, 1832(10):16131623. ［26］ Qiao HP, Gao WS, Huo JX, et al. Long noncoding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma［J］. Asian Pac J Cancer Prev, 2013, 14(2):10771082. ［27］ Zhang Z, Hao H, Zhang CJ, et al. Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer［J］. Zhonghua Yi Xue Za Zhi, 2012, 92(6):384387. ［28］ Han Y, Liu Y, Nie L, et al. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasisassociated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder［J］. Urology, 2013, 81(1):209.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.